Tag: kidney biopsy market drivers

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Kidney Biopsy Market Size And Revenue Forecast Through 2030

The kidney biopsy sector has witnessed robust expansion lately, projecting an increase from $2.26 billion in 2025 to $2.38 billion in 2026, fueled by a compound annual growth rate of 5.4%. This historical upswing is attributable to a confluence of factors, including the escalating prevalence of chronic kidney disease, a rise in the incidence of glomerulonephritis and nephrotic syndrome, the continued diagnostic importance of renal biopsies in clinical practice, a growing number of kidney transplantations, and the proliferation of tertiary care facilities.

The market for kidney biopsies is projected for consistent expansion over the upcoming years, reaching an estimated $2.86 billion by 2030, fueled by a compound annual growth rate of 4.7%. This anticipated expansion during the forecast period is largely attributable to the escalating prevalence of kidney issues linked to diabetes, the increasing acceptance of biopsy procedures guided by ultrasound and CT scans, a heightened need for prompt identification of kidney ailments, ongoing progress in imaging technologies, and broader availability of expert nephrology services. Key developments expected within this timeframe include a stronger inclination towards less invasive kidney biopsy methods, a greater utilization of percutaneous biopsies performed under image guidance, a growing requirement for precise diagnosis of kidney conditions, the wider application of biopsy procedures for monitoring transplanted kidneys, and enhancements in the safety and accuracy of renal tissue acquisition.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Kidney Biopsy Market Expansion Supported By Key Demand Factors

The increasing occurrence of kidney cancer is anticipated to be a primary driver for the kidney biopsy market’s expansion. This type of cancer, marked by the aberrant proliferation of kidney cells, is becoming more prevalent due to elements like altered lifestyles, exposure to environmental contaminants, and enhanced diagnostic capabilities leading to a greater number of identified cases. Kidney biopsies are instrumental in the diagnosis and management of renal cancer, serving to verify malignant cells, establish a cancer’s stage, inform treatment strategies, track therapeutic efficacy, and offer insights into potential outcomes. For example, Cancer Research UK projects that new diagnoses of kidney cancer in the UK will climb from roughly 16,300 in 2023 to an estimated 21,900 by 2025, underscoring how the escalating rates of renal cancer are fueling the growth trajectory of the kidney biopsy market.

Kidney Biopsy Market Segment Analysis Highlighting Growth Areas

The kidney biopsy market covered in this report is segmented –

1) By Type: Percutaneous Biopsy, Surgical Biopsy

2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

3) By End-User: Hospitals And Clinics, Tertiary Care Centers, Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Kidney Biopsy Market Growth Trends Influencing Competitive Dynamics

Leading entities within the kidney biopsy sector are actively engaged in creating cutting-edge systems by incorporating artificial intelligence (AI) to elevate diagnostic precision, optimize clinical workflows, and ultimately improve patient prognoses. The integration of AI offers a significant advantage to kidney biopsy procedures by refining image interpretation, furnishing diagnostic assistance, facilitating therapy design, delivering prognostic insights, and propelling kidney disease research forward. As a recent illustration, during March of 2024, Aiosyn, a software firm headquartered in the Netherlands, introduced its NephroPath platform. This NephroPath platform leverages advanced computational pathology algorithms designed to scrutinize histological markers present in kidney tissue samples, encompassing functions such as identifying distinct tissue classifications, quantifying interstitial fibrosis, and meticulously enumerating and evaluating glomeruli. Such AI-powered examination guarantees a uniform, thorough, and reliably repeatable evaluation of renal pathology indicators, thereby circumventing the limitations inherent in conventional scoring techniques and the variability introduced by individual observer interpretation.

Kidney Biopsy Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the kidney biopsy market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Cook Medical, B. Braun Melsungen AG, Merit Medical Systems Inc., Argon Medical Devices Inc., Stryker Corporation, Integra LifeSciences Corporation, Leica Biosystems, Hologic Inc., Samsung Medison Co. Ltd., Mindray Medical International Limited, Terumo Corporation, Fujifilm Holdings Corporation

Access The Complete Kidney Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Kidney Biopsy Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the kidney biopsy market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Kidney Biopsy Market Size And Revenue Forecast Through 2030

The kidney biopsy sector has witnessed robust expansion lately, projecting an increase from $2.26 billion in 2025 to $2.38 billion in 2026, fueled by a compound annual growth rate of 5.4%. This historical upswing is attributable to a confluence of factors, including the escalating prevalence of chronic kidney disease, a rise in the incidence of glomerulonephritis and nephrotic syndrome, the continued diagnostic importance of renal biopsies in clinical practice, a growing number of kidney transplantations, and the proliferation of tertiary care facilities.

The market for kidney biopsies is projected for consistent expansion over the upcoming years, reaching an estimated $2.86 billion by 2030, fueled by a compound annual growth rate of 4.7%. This anticipated expansion during the forecast period is largely attributable to the escalating prevalence of kidney issues linked to diabetes, the increasing acceptance of biopsy procedures guided by ultrasound and CT scans, a heightened need for prompt identification of kidney ailments, ongoing progress in imaging technologies, and broader availability of expert nephrology services. Key developments expected within this timeframe include a stronger inclination towards less invasive kidney biopsy methods, a greater utilization of percutaneous biopsies performed under image guidance, a growing requirement for precise diagnosis of kidney conditions, the wider application of biopsy procedures for monitoring transplanted kidneys, and enhancements in the safety and accuracy of renal tissue acquisition.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Kidney Biopsy Market Expansion Supported By Key Demand Factors

The increasing occurrence of kidney cancer is anticipated to be a primary driver for the kidney biopsy market’s expansion. This type of cancer, marked by the aberrant proliferation of kidney cells, is becoming more prevalent due to elements like altered lifestyles, exposure to environmental contaminants, and enhanced diagnostic capabilities leading to a greater number of identified cases. Kidney biopsies are instrumental in the diagnosis and management of renal cancer, serving to verify malignant cells, establish a cancer’s stage, inform treatment strategies, track therapeutic efficacy, and offer insights into potential outcomes. For example, Cancer Research UK projects that new diagnoses of kidney cancer in the UK will climb from roughly 16,300 in 2023 to an estimated 21,900 by 2025, underscoring how the escalating rates of renal cancer are fueling the growth trajectory of the kidney biopsy market.

Kidney Biopsy Market Segment Analysis Highlighting Growth Areas

The kidney biopsy market covered in this report is segmented –

1) By Type: Percutaneous Biopsy, Surgical Biopsy

2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

3) By End-User: Hospitals And Clinics, Tertiary Care Centers, Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Kidney Biopsy Market Growth Trends Influencing Competitive Dynamics

Leading entities within the kidney biopsy sector are actively engaged in creating cutting-edge systems by incorporating artificial intelligence (AI) to elevate diagnostic precision, optimize clinical workflows, and ultimately improve patient prognoses. The integration of AI offers a significant advantage to kidney biopsy procedures by refining image interpretation, furnishing diagnostic assistance, facilitating therapy design, delivering prognostic insights, and propelling kidney disease research forward. As a recent illustration, during March of 2024, Aiosyn, a software firm headquartered in the Netherlands, introduced its NephroPath platform. This NephroPath platform leverages advanced computational pathology algorithms designed to scrutinize histological markers present in kidney tissue samples, encompassing functions such as identifying distinct tissue classifications, quantifying interstitial fibrosis, and meticulously enumerating and evaluating glomeruli. Such AI-powered examination guarantees a uniform, thorough, and reliably repeatable evaluation of renal pathology indicators, thereby circumventing the limitations inherent in conventional scoring techniques and the variability introduced by individual observer interpretation.

Kidney Biopsy Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the kidney biopsy market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Cook Medical, B. Braun Melsungen AG, Merit Medical Systems Inc., Argon Medical Devices Inc., Stryker Corporation, Integra LifeSciences Corporation, Leica Biosystems, Hologic Inc., Samsung Medison Co. Ltd., Mindray Medical International Limited, Terumo Corporation, Fujifilm Holdings Corporation

Access The Complete Kidney Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Kidney Biopsy Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the kidney biopsy market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Kidney Biopsy Market Size And Revenue Forecast Through 2030

The kidney biopsy sector has witnessed robust expansion lately, projecting an increase from $2.26 billion in 2025 to $2.38 billion in 2026, fueled by a compound annual growth rate of 5.4%. This historical upswing is attributable to a confluence of factors, including the escalating prevalence of chronic kidney disease, a rise in the incidence of glomerulonephritis and nephrotic syndrome, the continued diagnostic importance of renal biopsies in clinical practice, a growing number of kidney transplantations, and the proliferation of tertiary care facilities.

The market for kidney biopsies is projected for consistent expansion over the upcoming years, reaching an estimated $2.86 billion by 2030, fueled by a compound annual growth rate of 4.7%. This anticipated expansion during the forecast period is largely attributable to the escalating prevalence of kidney issues linked to diabetes, the increasing acceptance of biopsy procedures guided by ultrasound and CT scans, a heightened need for prompt identification of kidney ailments, ongoing progress in imaging technologies, and broader availability of expert nephrology services. Key developments expected within this timeframe include a stronger inclination towards less invasive kidney biopsy methods, a greater utilization of percutaneous biopsies performed under image guidance, a growing requirement for precise diagnosis of kidney conditions, the wider application of biopsy procedures for monitoring transplanted kidneys, and enhancements in the safety and accuracy of renal tissue acquisition.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Kidney Biopsy Market Expansion Supported By Key Demand Factors

The increasing occurrence of kidney cancer is anticipated to be a primary driver for the kidney biopsy market’s expansion. This type of cancer, marked by the aberrant proliferation of kidney cells, is becoming more prevalent due to elements like altered lifestyles, exposure to environmental contaminants, and enhanced diagnostic capabilities leading to a greater number of identified cases. Kidney biopsies are instrumental in the diagnosis and management of renal cancer, serving to verify malignant cells, establish a cancer’s stage, inform treatment strategies, track therapeutic efficacy, and offer insights into potential outcomes. For example, Cancer Research UK projects that new diagnoses of kidney cancer in the UK will climb from roughly 16,300 in 2023 to an estimated 21,900 by 2025, underscoring how the escalating rates of renal cancer are fueling the growth trajectory of the kidney biopsy market.

Kidney Biopsy Market Segment Analysis Highlighting Growth Areas

The kidney biopsy market covered in this report is segmented –

1) By Type: Percutaneous Biopsy, Surgical Biopsy

2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

3) By End-User: Hospitals And Clinics, Tertiary Care Centers, Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Kidney Biopsy Market Growth Trends Influencing Competitive Dynamics

Leading entities within the kidney biopsy sector are actively engaged in creating cutting-edge systems by incorporating artificial intelligence (AI) to elevate diagnostic precision, optimize clinical workflows, and ultimately improve patient prognoses. The integration of AI offers a significant advantage to kidney biopsy procedures by refining image interpretation, furnishing diagnostic assistance, facilitating therapy design, delivering prognostic insights, and propelling kidney disease research forward. As a recent illustration, during March of 2024, Aiosyn, a software firm headquartered in the Netherlands, introduced its NephroPath platform. This NephroPath platform leverages advanced computational pathology algorithms designed to scrutinize histological markers present in kidney tissue samples, encompassing functions such as identifying distinct tissue classifications, quantifying interstitial fibrosis, and meticulously enumerating and evaluating glomeruli. Such AI-powered examination guarantees a uniform, thorough, and reliably repeatable evaluation of renal pathology indicators, thereby circumventing the limitations inherent in conventional scoring techniques and the variability introduced by individual observer interpretation.

Kidney Biopsy Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the kidney biopsy market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Cook Medical, B. Braun Melsungen AG, Merit Medical Systems Inc., Argon Medical Devices Inc., Stryker Corporation, Integra LifeSciences Corporation, Leica Biosystems, Hologic Inc., Samsung Medison Co. Ltd., Mindray Medical International Limited, Terumo Corporation, Fujifilm Holdings Corporation

Access The Complete Kidney Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Kidney Biopsy Market Largest Region: Which Geography Holds The Highest Market Share?

North Americawas the largest region in the kidney biopsy market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Size Of The Kidney Biopsy Market In 2026 And How Much Will It Reach By 2030?

The kidney biopsy market size has shown strong growth in recent years. It is anticipated to expand from $2.26 billion in 2025 to $2.38 billion in 2026, with a compound annual growth rate (CAGR) of 5.4%. This past growth can be attributed to the rising prevalence of chronic kidney disease, an increasing incidence of glomerulonephritis and nephrotic syndrome, the established clinical reliance on renal biopsy for diagnosis, an increase in kidney transplant procedures, and the expansion of tertiary care hospitals.

The kidney biopsy market is projected to experience consistent growth over the coming years, with its size expected to reach $2.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.7%. This expansion during the forecast period is primarily driven by the escalating incidence of diabetes-related kidney conditions, the increased adoption of ultrasound- and CT-guided biopsy techniques, a heightened demand for early diagnosis of kidney diseases, continuous advancements in imaging technologies, and improved access to specialized nephrology care. Key trends anticipated in this period include a growing preference for minimally invasive kidney biopsy procedures, the rising utilization of image-guided percutaneous biopsies, an increasing need for accurate renal disease diagnosis, the broader application of biopsy procedures for transplant monitoring, and enhanced safety and precision in obtaining renal tissue samples.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Which Core Factors Are Supporting The Expansion Of The Kidney Biopsy Market?

The escalating incidence of renal cancer is projected to stimulate the expansion of the kidney biopsy market in the foreseeable future. This condition is defined by the unrestrained multiplication of anomalous kidney cells. The increasing occurrence of renal cancer can be linked to elements like evolving lifestyles, environmental contaminants, and improved detection technologies that contribute to more diagnoses. A kidney biopsy is instrumental in diagnosing and overseeing renal cancer by verifying the existence of malignant cells, ascertaining the cancer’s grade, strategizing treatment, tracking how patients respond to therapy, and delivering information for prognosis. For instance, according to Cancer Research UK, new kidney cancer cases are anticipated to climb from approximately 16,300 in 2023 to about 21,900 in 2025. Thus, the growing incidence of renal cancer is a significant impetus behind the growth of the kidney biopsy market.

How Does Segment Analysis Break Down The Kidney Biopsy Market Structure?

The kidney biopsy market covered in this report is segmented –

1) By Type: Percutaneous Biopsy, Surgical Biopsy

2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

3) By End-User: Hospitals And Clinics, Tertiary Care Centers, Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

What Trends Are Affecting The Kidney Biopsy Market Dynamics?

Major companies engaged in the kidney biopsy market are developing advanced platforms by integrating artificial intelligence (AI) to improve diagnostic precision, optimize procedures, and enhance patient outcomes. Artificial intelligence (AI) elevates kidney biopsy by refining image analysis, offering diagnostic assistance, aiding in treatment formulation, providing predictive insights, and furthering research in kidney ailments. For example, in March 2024, Aiosyn, a software company headquartered in the Netherlands, introduced the NephroPath platform. The NephroPath platform utilizes computational pathology algorithms to examine histological biomarkers in kidney biopsies, including recognizing tissue types, quantifying interstitial fibrosis, and precisely counting and evaluating glomeruli. This AI-powered analysis guarantees uniform, comprehensive, and repeatable scoring of renal pathology biomarkers, addressing the deficiencies of conventional scoring approaches and observer bias.

Who Are The Companies Shaping The Kidney Biopsy Market Landscape?

Major companies operating in the kidney biopsy market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Cook Medical, B. Braun Melsungen AG, Merit Medical Systems Inc., Argon Medical Devices Inc., Stryker Corporation, Integra LifeSciences Corporation, Leica Biosystems, Hologic Inc., Samsung Medison Co. Ltd., Mindray Medical International Limited, Terumo Corporation, Fujifilm Holdings Corporation

Access The Complete Kidney Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Which Region Stands As The Largest Contributor To The Kidney Biopsy Market?

North America was the largest region in the kidney biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Kidney Biopsy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16458&type=smp

Browse Through More Reports Similar to the Global Kidney Biopsy Market 2026, By The Business Research Company

Kidney Cancer Diagnostics And Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report

Kidney Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Liquid Biopsy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Kidney Biopsy Market From 2026 To 2030?

The kidney biopsy market’s size has demonstrated strong growth in recent years. It is projected to expand from $2.26 billion in 2025 to $2.38 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.4%. The historical expansion can be attributed to factors such as the increasing prevalence of chronic kidney disease, a rise in the incidence of glomerulonephritis and nephrotic syndrome, the established clinical dependence on renal biopsy for diagnosis, an increase in kidney transplant procedures, and the broadening reach of tertiary care hospitals.

The kidney biopsy market is projected to experience consistent growth in the coming years. It is anticipated to reach a valuation of $2.86 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This expansion during the forecast period can be attributed to several factors, including the increasing prevalence of diabetes-related kidney conditions, the growing implementation of ultrasound- and CT-guided biopsy methods, a heightened need for early diagnosis of kidney disease, continuous advancements in imaging technologies, and broadened availability of specialized nephrology services. Key trends expected in this period include a rising preference for less invasive kidney biopsy approaches, increased utilization of image-guided percutaneous biopsies, a greater imperative for precise renal disease diagnosis, the extended application of biopsy procedures in monitoring organ transplants, and enhanced safety and accuracy in obtaining renal tissue samples.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Which Major Drivers Are Influencing The Expansion Of The Kidney Biopsy Market?

The anticipated increase in renal cancer cases is projected to drive the expansion of the kidney biopsy market going forward. Renal cancer is defined by the uncontrolled proliferation of abnormal kidney cells. This surge in renal cancer incidence is attributed to elements such as lifestyle changes, environmental toxins, and enhanced detection techniques resulting in more diagnoses. A kidney biopsy is crucial for both diagnosing and managing renal cancer by confirming the existence of cancerous cells, determining the cancer’s grade, aiding in treatment planning, monitoring the response to treatment, and offering prognostic information. For instance, according to Cancer Research UK, a UK-based cancer research organization, new kidney cancer cases are expected to increase from approximately 16,300 in 2023 to about 21,900 in 2025. Consequently, the rising incidence of renal cancer is a primary catalyst for the growth of the kidney biopsy market.

How Is The Kidney Biopsy Market Organized By Segment Classification?

The kidney biopsy market covered in this report is segmented –

1) By Type: Percutaneous Biopsy, Surgical Biopsy

2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

3) By End-User: Hospitals And Clinics, Tertiary Care Centers, Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Which Trends Are Shaping The Kidney Biopsy Market?

Leading companies engaged in the kidney biopsy market are innovating by developing platforms integrated with artificial intelligence (AI) to boost diagnostic accuracy, streamline procedures, and improve patient health outcomes. Artificial intelligence enhances kidney biopsy by refining image analysis, offering diagnostic assistance, aiding in treatment formulation, providing predictive insights, and advancing research into kidney diseases. For example, in March 2024, Aiosyn, a software company based in the Netherlands, introduced the NephroPath platform. The NephroPath platform utilizes computational pathology algorithms to analyze histological biomarkers present in kidney biopsies, encompassing the identification of tissue types, measurement of interstitial fibrosis, and precise counting and evaluation of glomeruli. This AI-driven analysis ensures consistent, detailed, and reproducible scoring of renal pathology biomarkers, effectively addressing the shortcomings of traditional scoring methods and the variability of observer interpretation.

Who Are The Industry Participants Involved In The Kidney Biopsy Market?

Major companies operating in the kidney biopsy market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Cook Medical, B. Braun Melsungen AG, Merit Medical Systems Inc., Argon Medical Devices Inc., Stryker Corporation, Integra LifeSciences Corporation, Leica Biosystems, Hologic Inc., Samsung Medison Co. Ltd., Mindray Medical International Limited, Terumo Corporation, Fujifilm Holdings Corporation

Get The Full Kidney Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Which Region Is The Top Contributor To The Kidney Biopsy Market By Share?

North America was the largest region in the kidney biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Kidney Biopsy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Browse Through More Reports Similar to the Global Kidney Biopsy Market 2026, By The Business Research Company

Kidney Cancer Diagnostics And Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report

Kidney Disease Market Report

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Liquid Biopsy Market Report

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model